20 March 2024, Melbourne, Australia: VivaZome Therapeutics Pty Ltd and La Trobe University are pleased to announce that they will be collaborating to explore the therapeutic potential for VivaZome’s extracellular vesicles (EVs) in models of stroke in the laboratory of Professor Chris Sobey (pictured).  This collaborative effort brings together VivaZome’s expertise in EV manufacturing and La Trobe’s stroke research capabilities led by Professor Sobey. The study entitled “Anti-inflammatory exosomes for stroke: a proof-of-concept (PoC) pilot study” is supported by a $300k grant from the La Trobe Proof-of-Concept (PoC) Fund. Click here to read the media release.